The COVID-19 pandemic has posed unique risks to people with Alzheimer disease and
dementia. Research from 2020 has shown that these people have a relatively high risk of …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) triggered the pandemic
Coronavirus Disease 19 (COVID-19), causing millions of deaths. The elderly and those …

COVID-19, the global threat to humanity, shares etiological cofactors with multiple diseases
including Alzheimer's disease (AD). Understanding the common links between COVID-19 …

Introduction The increasing evidence of SARS‐CoV‐2 impact on the central nervous system
(CNS) raises key questions on its impact for risk of later life cognitive decline, Alzheimer's …

Abstract Background: Coronavirus disease 2019 (COVID-19), the far-reaching pandemic,
has infected approximately 185 million of the world's population to date. After infection …

There are a number of potential implications for the field of Alzheimer's disease (AD)
stemming from the global spread of SARS-CoV-2. Neuroinflammation is known to be a …

In the middle of the coronavirus disease 19 (COVID-19) outbreak, the main efforts of the
scientific community are rightly all focused on identifying efficient pharmacological …

Cognitive impairment following SARS-CoV-2 infection is being increasingly recognized as
an acute and possibly also long-term sequela of the disease. Direct viral entry as well as …

The impact of coronavirus disease 2019 (COVID-19) pandemic on patients with
neurodegenerative diseases and the specific neurological manifestations of COVID-19 have …

Background: Cognitive decline is a common consequence of COVID-19, and studies
suggest a link between COVID-19 and Alzheimer's disease (AD). However, the molecular …